I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase I clinical and pharmacokinetic study of PM01183 (a te..:
Paz-Ares, Luis
;
Forster, Martin
;
Boni, Valentina
...
http://hdl.handle.net/10668/10626. , 2016
Link:
http://hdl.handle.net/10668/10626
RT Journal T1
Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_10626&Exemplar=1&LAN=DE A1 Paz-Ares, Luis A1 Forster, Martin A1 Boni, Valentina A1 Szyldergemajn, Sergio A1 Corral, Jesús A1 Turnbull, Samantha A1 Cubillo, Antonio A1 Teruel, Carlos Fernandez A1 Calderero, Iker López A1 Siguero, Mariano A1 Bohan, Patrick A1 Calvo, Emiliano YR 2016 K1 Combination K1 Gemcitabine K1 Lurbinectedin K1 PM01183 K1 Solid tumor K1 Adult K1 Aged K1 Antineoplastic Agents K1 Antineoplastic Combined Chemotherapy Protocols K1 Carbolines K1 Deoxycytidine K1 Disease-Free Survival K1 Female K1 Heterocyclic Compounds K1 4 or More Rings K1 Humans K1 Male K1 Middle Aged K1 Neoplasms K1 Treatment Outcome JF http://hdl.handle.net/10668/10626 LK http://hdl.handle.net/10668/10626 DO http://hdl.handle.net/10668/10626 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)